Glaucoma News

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Savas Komban, CEO and co-founder of Smartlens, discusses developments in unmet needs in glaucoma, including IOP assessment.

NEW YORK — In a presentation at OSN New York, Manjool Shah, MD, discusses how surgeons can identify patients with glaucoma who may benefit from transscleral gel stents and provides tips to prepare for an effective surgery.

In this exclusive surgical video for Healio/OSN, I. Paul Singh, MD, demonstrates accessing the collector channels using the KDB Glide, a device for advanced excisional goniotomy.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, I. Paul Singh, MD, discusses intraoperative OCT and how it is utilized within the glaucoma conventional outflow pathway space and even subconjunctival surgery.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Brian A. Francis, MD, discusses the advantages of inflow vs. outflow minimally invasive glaucoma surgery procedures.

KOLOA, Hawaii — Gonioscopy-assisted transluminal trabeculotomy has shown positive results for the treatment of myocilin glaucoma, according to a presenter here.

KOLOA, Hawaii — Cataract surgeons may need to monitor patients with glaucoma more than the average cataract patient, including discussing vision expectations and future IOP management, according to a speaker here.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Shawn O’Neil of ViaLase discusses positive 24-month safety and efficacy data for the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.

A case-crossover study conducted on a large health care database in South Korea shed light on the association between acute angle-closure glaucoma and a number of prescription and nonprescription medications.

Glaukos reported positive results in a clinical trial investigating the safety of the surgical exchange procedure for the iDose TR in subjects who had previously received the implant in a phase 2b clinical trial.